Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
GHK-Cu is 50 of the 70 mg (71%) of the blend, so each dose is dominated by GHK-Cu with BPC-157 and TB-500 as minority support peptides
Conditions that shorten red cell lifespan such as haemolytic anaemia or acute blood loss mean cells spend less time in circulation and accumulate less glycated haemoglobin, producing a spuriously low HbA1c even when blood glucose is elevated
KEY FEATURES High-purity AOD-9604 research peptide 5mg lyophilised powder per vial HPLC-MS verified purity (99.08%) Manufactured in accredited laboratories Sterile, tamper-evident vial suitable for laboratory handling Fast, discreet Australia-wide shipping SPECIFICATIONS Product Name AOD-9604 5mg Peptide Grade Research Grade Quantity 5mg per vial Form Lyophilised powder Purity 99.08% (HPLC-MS tested) Appearance White/off-white lyophilised powder Storage Conditions Cool, dry environment
Disclosure of interest: Pik Ee Chan: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2197 - ESOC25-418 RES-Q REGISTRY FOR ASSESSING STROKE CARE QUALITY IN N.MACEDONIA (2017-2024) Anita Arsovska 1 1 University Clinic of Neurology, University "Ss
